Mechanism of action
Place your order for preplated version of libraries or request for customization and we configure the best screening set for your projects and inventory.
Write usProduct name
Size
Description
Download
13,000 compounds
RORγ Library is small molecules set targeted against autoimmune diseases.
5,886 compounds
SH2 PTB domains Focused Library is a set of inhibitors. SH2 and PTB are small protein modules that mediate PPIs involved in signal transduction pathways.
31,000 compounds
PRMT Library is set of small-molecule compounds with reported affinity against cancer-assosiated PRMTs.
4,003 compounds
Small molecules that can inhibit NOTUM thus potentially treating diseases caused by dysregulation of Wnt signaling.
4,805 compounds
MEF2-HDAC (class II) Modulators Library is a set of drug-like compounds aimed at modulating PPI of MEF2 with HDAC involved in physiological processes.
23,319 compounds
MDM2-p53 Interaction Inhibitors Library is a set of drug-like compounds aimed at modulating PPI of MDM2 with p53 involved in tumorigenesis.
5,000 compounds
Carbonic anhydrase II library is a set of compounds belonging to the sulfonamides, mercaptans and phenols aimed at modulating of Carbonic anhydrase II activity
15,080 compounds
Molecules from c-Met Library target receptor tyrosine kinase. It prevents binding hepatocyte growth factor with c-Met which can lead to cancer.
11,568 compounds
Bcl2 PPI Inhibitors Library is small molecules that inhibit regulators of programmed cell death.
4,244 compounds
Androgen Receptor Antagonists Library is a set of non-steroidal small molecules for prostate cancer treatment.
3,271 compounds
Purinergic Library is a set of purinergic receptor antagonists. Such antagonists are used for thrombosis and stroke treatment.
40,000 compounds
Small-molecule compounds that can be used in GPCR drug discovery. Dysregulation of these receptors causes diabetes, CNS disorders.
7,123 compounds
Set of GABA receptor antagonists. These drug-like compounds inhibit the action of GABA and produce stimulant and convulsant effects.
3,000 compounds
Neuropeptide S Library is a set of small-molecule NPSR ligands. They can be used in psychiatric disorders treatment as anxiolytics and analgesics.
21000 compounds
Adenosine Receptors Targeted Library is a set of small-molecule ligands. They can be used for treating neurodegeneration diseases.
3,900 compounds
RPTP Targeted Library is small-molecule inhibitors. Disruption of protein tyrosine phosphorylation contributes to a variety of human diseases.
6,767 compounds
Set of RAR receptor antagonists. The retinoic acid receptor is a type of nuclear receptor which can also act as a transcription factor.
5,000 compounds
Glucocorticoid Receptors Library is small-molecule selective modulators of GR which regulates gene transcription.
597 compounds
TLR-8 Ligands Library is a set of small-molecule TLR-8 agonists. They can be used in adjuvantation research and for the treatment of ovarian cancer.
5,939 compounds
STING Agonist Library is small-molecules that bind and activate STING and lead to IFN production. Can be used in cancer immunotherapy.
20,563 compounds
Spiro Library is a set of scaffolds with twisted structure of two or more rings for the design of new therapeutic agents.
12,000 compounds
SH2 Domain Library is a set of inhibitors. SH2 are modular units, which bind to tyrosyl-phosphorylated peptide on their target protein mediating PPI.
23,943 compounds
Recognition Elements PPI Library includes conformationally constrained analogues of bioactive peptides: gamma-, beta-turns, dipeptide mimetics.
214,102 compounds
PPI Library is a set of small-molecule modulators that have been designed for disrupting PPI and reducing its drawbacks.
23,722 compounds
PPI Tripeptide Mimetics Library is small-molecule PPI inhibitors that mimic significant endogenous tripeptides.
68,388 compounds
PPI Helix Turn 3D Mimetics Library was designed on sp3-enriched scaffolds that mimic key recognition elements of protein secondary structure.
2,679 compounds
Small-molecule compounds that mimic the action of protein and modulates PPI.
36,711 compounds
Small molecules that mimic the action of peptides thus modulating PPI. Protein secondary structures are targets for mimicry.
3,055 compounds
Selective small-molecule PDZ inhibitors. They help to overcome drawbacks of PPI.
19,079 compounds
Library contains nonpeptide small-molecules that inhibit PPI. They are structural mimetics to target proteins.
2,335 compounds
Macrocycles Library is a set of macrocyclic peptidomimetics that are potential PPI modulators. It is unique spiro and fused scaffolds.
12,103 compounds
Eccentric PPI Library is a set of unusual ring systems (scaffolds) that lie outside the field of (hetero)aromatic systems.
9,487 compounds
Set of PPI modulators. Cyclic lactam amides result from the Ugi reaction of bifunctional keto carboxylic acids.
4200 compounds
The use of covalently binding inhibitors is steadily growing, with numerous molecules progressing through the stages of clinical trials and even make it to become marketed drugs.
5,816 compounds
Bromodomain Modulators Library is a set of drug-like compounds aimed at modulating PPI of bromodomain-containing proteins with other vital proteins.
24,737 compounds
Alpha-Helix Mimetics Library is a set of peptidomimetics. Alpha-helices are key recognition elements of protein secondary structure.
20,000 compounds
Chemokine Receptor Targeted Library is a set of small-molecule ligands. Modulation of chemokine receptor is used in the treatment of inflammatory diseases.
9,769 compounds
Set of small-molecule HDAC inhibitors. HDAC regulate gene expression and its inhibitors act against cancers, neurodegenerative and inflammatory diseases.
21,000 compounds
Epitranscriptome Focused Small Molecule Library modulates the activity of proteins involving in aberrant RNA modification.
25,883 compounds
Focused Epigenetics Library is a set of small-molecule modulators that target epigenetic proteins.
50,410 compounds
Anti-Aging Library is small molecules targeting cellular pathways and biological targets that are implicated in aging.
Tags
Custom ChemistryNovel Scaffolds and Discovery LibrariesCustom Building Blocks for DNA Encoded LibrariesScale up SynthesisMacrocycle CompoundsIn silico Drug Design (CADD)PROTACADME, DMPKMedicinal ChemistryDNA Encoded Libraries-CDI-CapabilitiesDiscovery BiologyAssay DevelopmentHigh Throughput Screening (HTS)Animal ModelsToxicology and SafetyChemistry, Manufacturing and ControlsPre-Plated SetRepresentative CompoundsNatural-Product3D-PharmacophoreMCE-18RepresentativeSoluble DiversityTargeted DiversitySmartTMAntiviralGPCR3DPhenotypic ScreeningCNS activityTranscription FactorsDrugs LibraryTarget ActivityTherapeutical DiversityCNSIon ChannelsProteases HumanKinases HumanPhosphatases HumanReceptors HumanOpportunistic PathogensCancerCardiovascularMetabolicImmune systemInfectionsMusculoskeletalDigestive systemRespiratory tractOtorhinolaryngologicNervous systemEyeMaleFemaleHemic and lymphaticCongenitalSkinEndocrineAnimalWoundsKinasesProteasesPhosphatasesNuclear receptorsOthersPPI modulatorsReceptor's ligandsEpigeneticMimeticsCyclic compoundsFragmentsPoolChemical classes AgroAllosteric Inhibitors